Health Condition 1: H521- Myopia
Conditions
Interventions
Intervention1: Atropine: 0.01% Atropine eyedrops HS only in the randomised eye for 1 year
Control Intervention1: NIL: Other eye is not treated and will be used as the comparator to the treated eye.The
Sponsors
Dr Abraham Kurian
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children or Young adults in the age group 5-15 years. 2. Myopic refractive error of spherical equivalent > 1.00D as measured by cycloplegic refraction 3. Astigmatism of 4. Documented progression of myopia 5. Ability to understand and follow the study instructions you receive and likely to be amenable for 1 year followup. 6. Normal ocular health other than refractive error 7. Normal Intraocular pressure (
Exclusion criteria
Exclusion criteria: 1. Known Allergy or hypersensitivity to Atropine, Cyclopentolate, Phenyl ephrine or Proparacaine 2. Amblyopia in atleast one eye 3. History of significant cardiac or respiratory illness 4. Current enrolment in another investigational study or participation in such a study within 30 days of entry into this study 5. No previous or current use of contact lenses or bifocals or progressive lenses or other forms of treatment (including Atropine in any strength) for myopia 6. Patient has a condition or situation which in the investigators opinion, may put the patient at a significant risk, may confound the study results, or interfere with the participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression of myopia in terms of Spherical equivalent in realtion to baselineTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in axial length with respect to the baseline measurement.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Abraham Kurian
Chaithanya Eye Hospital and Research Institute, Kesavadasapuram, Trivandrum
Outcome results
None listed